Observational studyEuropean journal of pediatrics2025

Public health impact of nirsevimab and reduction of RSV hospitalisation in all infants: early real-world data from Tuscany (Italy) in the 2024-25 RSV season.

Francesco Nieddu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.